Medial prefrontal cortical NMDA receptors regulate depression-like behavior and dictate limbic thalamus innervation
Oliver H MilleriD, Andreas BrunsiD, Imen Ben Ammar, Thomas Mueggler, Benjamin J. HalliD
Abstract
Depression is a pervasive and debilitating neuropsychiatric disorder. A single, low dose of the NMDA receptor (NMDAR) antagonist ketamine elicits a long-lasting antidepressant response in patients with treatment-resistant major depressive disorder. Developing mechanistic understanding of how NMDAR antagonism alters synapse and circuit function is pivotal to developing translatable, circuit-based therapies for depression. Here using viral vectors, anatomical tracing, fMRI, and optogenetic-assisted circuit analysis, we assessed the role of the NMDAR subunit GluN2B in regulating cellular, synaptic, and circuit-level function and depression-related behavior. We demonstrate that post-developmental deletion of GluN2B from pyramidal neurons in medial prefrontal cortex enhances action potential output in a synaptic activity-dependent manner. GluN2B deletion dictates functional connectivity between mPFC and limbic thalamus but not ventral hippocampus and elicits antidepressant-like behavior. Our findings demonstrate that postsynaptic GluN2B exerts input-specific control of pyramidal neuron innervation, and identify a novel circuit for regulating depression-like behaviors in mice.
02 /Specification & Classification
Click any tag to browse matching papers- Citations
- 70
- FWCI
- 5.72
- Field percentile
- top 3%
- Organism
- Approach
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- A novel antidepressant acting via allosteric inhibition of GluN2D-incorporated NMDA receptors at GABAergic interneurons
Jilin Zhang, Jinjin Duan, … Fei Guo·bioRxiv·Nov 6, 2022
- Effects of ketamine on GABAergic and glutamatergic activity in the mPFC: biphasic recruitment of GABA function in antidepressant-like responses
Manoela V. Fogaça, Fernanda Daher, Marina R. Picciotto·NeuropsychopharmacologyPeer-reviewed·Oct 10, 2024
- Ketamine disrupts neuromodulatory control of glutamatergic synaptic transmission.
György Lür, Mona Fariborzi, Michael J. Higley·PLoS ONEPeer-reviewed·Mar 13, 2019
- Cortical and raphe GABAA, AMPA receptors and glial GLT-1 glutamate transporter contribute to the sustained antidepressant activity of ketamine
Thu Ha Pham, Céline Defaix, … Alain Michel Gardier·Pharmacology Biochemistry and BehaviorPeer-reviewed·Mar 19, 2020
- Role of the medial prefrontal cortex in the effects of rapid acting antidepressants on decision-making biases in rodents
Claire A. Hales, JM Bartlett, … Emma S. J. Robinson·NeuropsychopharmacologyPeer-reviewed·Aug 25, 2020
- CCL5/CCR5 signaling modulates depression-relevant behavior, neuronal oscillations, and long-term depression of synaptic activity.
Katie Hummel, Lara Stefansson, … Katherine E. Conant·bioRxiv·Sep 12, 2025